ABVX · Abivax S.A. · Debt
$90.20
-1.24 (-1.36%)
At close · Nov 12
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Market Cap
$7.90B
Shares
87.54M
Volume · Nov 12
692.05K
Avg daily vol (3M)
1.09M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Lease liabilities | 2026-06-30 | EUR 1,212,000 | 6-K filed 2026-09-21 |
| Other current borrowings | 2026-06-30 | EUR 1,075,000 | 6-K filed 2026-09-21 |
| Other noncurrent borrowings | 2026-06-30 | EUR 137,000 | 6-K filed 2026-09-21 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1956827
CUSIP
00370M103
13F (30d)
161 filings
153 filers
Visit website
Investor relations